CSIMarket
 


Eagle Pharmaceuticals inc   (EGRX)
Other Ticker:  
 
 

EGRX's Capital Expenditures Growth by Quarter and Year

Eagle Pharmaceuticals Inc 's Capital Expenditures results by quarter and year




EGRX Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.01 5.05 17.67
III Quarter September - 0.00 0.01 0.20
II Quarter June 0.01 0.00 0.00 0.00
I Quarter March 0.06 0.17 0.38 0.47
FY   0.07 0.18 5.44 18.34



EGRX Capital Expenditures second quarter 2023 Y/Y Growth Comment
Eagle Pharmaceuticals inc in the second quarter 2023 achieved Capital Expenditures of $ 0.01 millions compare to Capital Expenditures recorded in same quarter a year ago.

According to the results reported in the second quarter 2023, Eagle Pharmaceuticals Inc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Eagle Pharmaceuticals Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the second quarter 2023.




EGRX Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -99.8 % -71.42 % 13492.31 %
III Quarter September - - -95 % -33.33 %
II Quarter June - - - -
I Quarter March -64.71 % -55.26 % -19.15 % 161.11 %
FY   - -96.69 % -70.34 % 2251.28 %

Financial Statements
Eagle Pharmaceuticals Inc 's second quarter 2023 Capital Expenditures $ 0.01 millions EGRX's Income Statement
Eagle Pharmaceuticals Inc 's second quarter 2022 Capital Expenditures $ 0.00 millions Quarterly EGRX's Income Statement
New: More EGRX's historic Capital Expenditures Growth >>


EGRX Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - 50400 % 8735 %
III Quarter September - - - -
II Quarter June -90 % - - -
I Quarter March 500 % -96.63 % -97.85 % 261.54 %
FY (Year on Year)   - -96.69 % -70.34 % 2251.28 %




Capital Expenditures second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Eagle Pharmaceuticals Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
100880 % 6236.75 % -100 %
(Dec 31 2021)  


EGRX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2023 Eagle Pharmaceuticals Inc reported fall in Capital Expenditures sequentially by -90% to $ 0.01 millions, from $ 0.06 millions achived in the previous quarter.

Within Major Pharmaceutical Preparations industry 109 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Eagle Pharmaceuticals Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1954.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #110
Healthcare Sector #318
Overall #1954
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #110
Healthcare Sector #318
Overall #1954
Capital Expenditures Q/Q Growth Statistics
High Average Low
100880 % 6236.75 % -100 %
(Dec 31 2021)  


EGRX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2023 Eagle Pharmaceuticals Inc reported fall in Capital Expenditures from the previous quarter by -90% to $ 0.01 millions, from $ 0.06 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 109 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Eagle Pharmaceuticals Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1954.


Eagle Pharmaceuticals Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Jun 30 2023 period, Eagle Pharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Eagle Pharmaceuticals inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Jun 30 2023 period, Eagle Pharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Eagle Pharmaceuticals inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
EGRX's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for EGRX's Competitors
Capital Expenditures Growth for Eagle Pharmaceuticals Inc 's Suppliers
Capital Expenditures Growth for EGRX's Customers

You may also want to know
EGRX's Annual Growth Rates EGRX's Profitability Ratios EGRX's Asset Turnover Ratio EGRX's Dividend Growth
EGRX's Roe EGRX's Valuation Ratios EGRX's Financial Strength Ratios EGRX's Dividend Payout Ratio
EGRX's Roa EGRX's Inventory Turnover Ratio EGRX's Growth Rates EGRX's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2023
Blueprint Medicines Corporation-0.08%$ -0.078 millions
Iqvia Holdings Inc -0.62%$ -0.621 millions
Alnylam Pharmaceuticals Inc -0.85%$ -0.847 millions
Luna Innovations Inc-1.21%$ -1.213 millions
Inhibrx Inc -1.55%$ -1.553 millions
3m Company-1.82%$ -1.823 millions
Penumbra Inc -2.01%$ -2.009 millions
Prophase Labs Inc -2.08%$ -2.077 millions
Encompass Health Corporation-2.09%$ -2.089 millions
Verve Therapeutics Inc -2.10%$ -2.096 millions
Avanos Medical Inc -2.44%$ -2.439 millions
Caribou Biosciences Inc -2.56%$ -2.557 millions
Voyager Therapeutics Inc -2.58%$ -2.576 millions
Alkermes Plc -2.58%$ -2.580 millions
Poseida Therapeutics Inc -2.79%$ -2.791 millions
Gilead Sciences Inc -2.80%$ -2.797 millions
Harrow Inc -3.47%$ -3.475 millions
Brookdale Senior Living Inc -3.50%$ -3.498 millions
Electromed Inc -3.92%$ -3.922 millions
Dyne Therapeutics Inc -4.21%$ -4.215 millions
Co diagnostics Inc -4.60%$ -4.604 millions
Bristol myers Squibb Company-4.78%$ -4.779 millions
Apellis Pharmaceuticals Inc -4.86%$ -4.859 millions
Insulet Corporation-5.24%$ -5.236 millions
The Beauty Health Company-5.43%$ -5.435 millions
10x Genomics Inc -6.84%$ -6.844 millions
23andme Holding Co-6.90%$ -6.897 millions
Healthcare Services Group Inc -7.33%$ -7.332 millions
Livanova Plc-7.64%$ -7.638 millions
Dariohealth Corp -8.18%$ -8.176 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com